Cargando…

(18)F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma

PURPOSE: The role of (18)F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) in evaluating bone marrow (BM) involvement (BMI) among patients with extranodal natural killer/T-cell lymphoma (ENKTL) is poorly understood. This study investigated whether PET/C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chunli, Wu, Wanchun, Zhou, Huijie, Zhao, Sha, Tian, Rong, Xiang, Maya, Zou, Liqun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372794/ https://www.ncbi.nlm.nih.gov/pubmed/35965550 http://dx.doi.org/10.3389/fonc.2022.894804

Ejemplares similares

Comparison of the clinical efficacies of two L‐asparaginase‐based chemotherapy regimens for newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma
por: Wu, Wanchun, et al.
Publicado: (2023)

A controlling nutritional status score is an independent predictor for patients with newly diagnosed nasal‐type extranodal NK/T‐cell lymphoma based on asparaginase‐containing regimens
por: Wu, Wanchun, et al.
Publicado: (2023)

Prognostic significance of the systemic immune-inflammation index in patients with extranodal natural killer/T-cell lymphoma
por: Hai, Tao, et al.
Publicado: (2023)

Baseline SUVmax of (18)F-FDG PET-CT indicates prognosis of extranodal natural killer/T-cell lymphoma
por: Xia, Xianwu, et al.
Publicado: (2020)

FDG-PET/CT versus bone marrow biopsy in bone marrow involvement in newly diagnosed paediatric lymphoma: a systematic review and meta-analysis
por: Li, Zhizhuo, et al.
Publicado: (2021)

Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
por: Li, Hongyan, et al.
Publicado: (2021)

Detection of bone marrow involvement with FDG PET/CT in patients with newly diagnosed lymphoma
por: Özpolat, H. Tahsin, et al.
Publicado: (2018)

Comparing the diagnostic value of 18F-FDG PET/CT scan and bone marrow biopsy in newly diagnosed pediatric neuroblastoma and ganglioneuroblastoma
por: Fu, Zheng, et al.
Publicado: (2022)

Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
por: Kasalak, Ömer, et al.
Publicado: (2017)

Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using (18)F-FDG PET/CT and/or routine iliac crest biopsy? A new approach of PET/CT-guided targeted bone marrow biopsy
por: Hao, Bing, et al.
Publicado: (2018)

Weakly supervised deep learning for determining the prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T cell lymphoma, nasal type
por: Guo, Rui, et al.
Publicado: (2021)

Extranodal manifestations of lymphoma on [(18)F]FDG-PET/CT: a pictorial essay
por: Kashyap, Raghava, et al.
Publicado: (2011)

Isolated Extranodal Rosai-Dorfman Disease on 18F-FDG PET-CT Scan
por: Gupta, Nitin, et al.
Publicado: (2019)

Utility of baseline, interim and end-of-treatment (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma patients treated with L-asparaginase/pegaspargase
por: Chang, Yu, et al.
Publicado: (2017)

Prognostic value of baseline, interim and end-of-treatment (18)F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
por: Wang, Hongxi, et al.
Publicado: (2018)

Prognostic Value of Bone Marrow FDG Uptake Pattern of PET/CT in Newly Diagnosed Diffuse Large B-cell Lymphoma
por: Chen, Yumei, et al.
Publicado: (2018)

Five‐year analysis from phase 2 trial of “sandwich” chemoradiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphoma
por: Zhang, Li, et al.
Publicado: (2015)

Four rare extranodal sites seen on FDG PET/CT in a single patient of disseminated lymphoma
por: Puranik, Ameya D., et al.
Publicado: (2013)

Expression of Concern: Prognostic value of baseline, interim and end-of-treatment (18)F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis
Publicado: (2023)

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
por: Gill, Harinder, et al.
Publicado: (2010)

Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand
por: Lim, Yoo Li, et al.
Publicado: (2015)

Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
por: Althoff, Ashley, et al.
Publicado: (2017)

Metabolic activity of extranodal NK/T cell lymphoma on (18)F-FDG PET/CT according to immune subtyping
por: Lim, Chae Hong, et al.
Publicado: (2021)

Prognostic significance of peripheral blood absolute lymphocyte count and derived neutrophil to lymphocyte ratio in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
por: Zhou, Xiangxiang, et al.
Publicado: (2019)

Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics
por: Han, Eun Ji, et al.
Publicado: (2022)

Clinicopathological characteristics and treatment outcomes of cutaneous extranodal natural killer/T-cell lymphoma: a retrospective study in China
por: Chen, Xi, et al.
Publicado: (2020)

Quantification of FDG-PET/CT with delayed imaging in patients with newly diagnosed recurrent breast cancer
por: Baun, Christina, et al.
Publicado: (2018)

The value of routine bone marrow examination in patients with extranodal NK/T‐cell lymphoma staged with PET/CT
por: Yang, Yong, et al.
Publicado: (2022)

Clinical application of real-time PET/CT guided targeted retroperitoneal masses biopsy in diagnosing malignant tumors
por: Li, Xiaomin, et al.
Publicado: (2023)

Utility of PET/CT in the Diagnosis and Staging of Extranodal Natural Killer/T-Cell Lymphoma: A Systematic Review and Meta-Analysis
por: Zhou, Xiangxiang, et al.
Publicado: (2014)

Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis
por: Zuhaimy, Hanis, et al.
Publicado: (2017)

Prognosis estimation under the light of metabolic tumor parameters on initial FDG-PET/CT in patients with primary extranodal lymphoma
por: Okuyucu, Kursat, et al.
Publicado: (2016)

Non-Hodgkin lymphoma of multiple extranodal involvement seen on MRI, FDG PET–CT scans: A case report
por: Wang, Shan, et al.
Publicado: (2017)

A Case of Extranodal Testicular Involvement in Non-Hodgkin’s Lymphoma Detected through (18)F-FDG PET-CT
por: Coulier, B., et al.
Publicado: (2015)

Gemcitabine, dexamethasone, and cisplatin (GDP) chemotherapy with sandwiched radiotherapy in the treatment of newly diagnosed stage IE/IIE extranodal natural killer/T‐cell lymphoma, nasal type
por: Tian, Shu, et al.
Publicado: (2019)

FDG PET/CT and thyroid biopsy leads to neurosarcoidosis diagnosis
por: Bullock, Catherine, et al.
Publicado: (2023)

Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians
por: Zhou, Huijie, et al.
Publicado: (2023)

GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type
por: Wang, Jing-jing, et al.
Publicado: (2016)

18F-FDG PET/CT Imaging of Extranodal Rosai-Dorfman Disease with Hepatopancreatic Involvement - A Pictorial and Literature Review
por: Shaikh, Faiq, et al.
Publicado: (2015)

Evaluation of different staging systems and prognostic analysis of nasal-type extranodal NK/T-cell lymphoma based on consistent LVDP chemotherapy regimen
por: Wu, Wanchun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vgqubpb4o6a196a6r0loscrvg7